Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ASPHF

Ascentage Pharma Group International

USD

Set alert

Price alert · ASPHF

All alert types
3.75 USD 0.00 0.00%
As of Oct 29, 2026
3.46 Day range 3.46
3.46 52-week range 9.32
YTD
-55.78%
1 year
-59.76%
Open
3.46
Prev close
3.75
Mkt cap
1.40B
Vol
100
Avg vol
104
EPS
-0.56
P/E
0.00
More statistics
Low
3.46
High
3.46
Earnings
Aug 26, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ASPHF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.52 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -17.3×
FY 2016: -81.4×FY 2017: -69.6×FY 2018: -25.1×FY 2019: -3.3×FY 2020: -12.7×FY 2021: -12.6×FY 2022: -7.0×FY 2023: -6.9×FY 2024: -14.3×FY 2025: -17.3×
FY 2016 5y median -12.6× FY 2025
P/S 37.8×
FY 2016: 1144×FY 2017: 1299×FY 2018: 1276×FY 2019: 342×FY 2020: 690×FY 2021: 353×FY 2022: 29.5×FY 2023: 29.0×FY 2024: 5.9×FY 2025: 37.8×
FY 2016 5y median 29.5× FY 2025
P/B 15.9×
FY 2016: -600×FY 2017: -62.4×FY 2018: -8.6×FY 2019: 5.6×FY 2020: 10.2×FY 2021: 8.0×FY 2022: 15.1×FY 2023: 106×FY 2024: 22.0×FY 2025: 15.9×
FY 2016 5y median 15.9× FY 2025
P/FCF -17.6×
FY 2016: -178×FY 2017: -63.9×FY 2018: -30.2×FY 2019: -9.2×FY 2020: -10.0×FY 2021: -9.5×FY 2022: -7.2×FY 2023: -8.2×FY 2024: -42.8×FY 2025: -17.6×
FY 2016 5y median -9.5× FY 2025
EV/EBITDA -18.8×
FY 2016: -73.0×FY 2017: -95.7×FY 2018: -24.0×FY 2019: -2.9×FY 2020: -12.6×FY 2021: -11.7×FY 2022: -8.4×FY 2023: -9.6×FY 2024: -26.3×FY 2025: -18.8×
FY 2016 5y median -11.7× FY 2025
EV/Sales 36.9×
FY 2016: 1106×FY 2017: 1297×FY 2018: 1141×FY 2019: 288×FY 2020: 651×FY 2021: 330×FY 2022: 30.9×FY 2023: 32.2×FY 2024: 6.4×FY 2025: 36.9×
FY 2016 5y median 32.2× FY 2025
FCF Yield -5.7%
FY 2016: -0.6%FY 2017: -1.6%FY 2018: -3.3%FY 2019: -10.8%FY 2020: -10.0%FY 2021: -10.5%FY 2022: -13.9%FY 2023: -12.2%FY 2024: -2.3%FY 2025: -5.7%
FY 2016 5y median -10.5% FY 2025

Profitability

Gross Margin 76.4%
FY 2016: 96.6%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 85.6%FY 2020: 84.2%FY 2021: 88.1%FY 2022: 89.5%FY 2023: 86.2%FY 2024: 97.0%FY 2025: 76.4%
FY 2016 5y median 88.1% FY 2025
Operating Margin -211.1%
FY 2016: -1533.8%FY 2017: -1553.1%FY 2018: -5032.1%FY 2019: -4224.6%FY 2020: -5497.4%FY 2021: -3343.5%FY 2022: -421.2%FY 2023: -393.1%FY 2024: -37.7%FY 2025: -211.1%
FY 2016 5y median -393.1% FY 2025
Net Margin -216.5%
FY 2016: -1406.5%FY 2017: -1872.9%FY 2018: -5072.8%FY 2019: -10202.7%FY 2020: -5442.6%FY 2021: -2803.4%FY 2022: -421.0%FY 2023: -417.0%FY 2024: -41.3%FY 2025: -216.5%
FY 2016 5y median -417.0% FY 2025
ROE -91.4%
FY 2016: 738.3%FY 2017: 89.9%FY 2018: 34.1%FY 2019: -166.3%FY 2020: -80.0%FY 2021: -63.4%FY 2022: -216.1%FY 2023: -1532.1%FY 2024: -153.5%FY 2025: -91.4%
FY 2016 5y median -153.5% FY 2025
ROIC -33.2%
FY 2016: -20.0%FY 2017: -19.2%FY 2018: -29.3%FY 2019: -57.2%FY 2020: -47.1%FY 2021: -34.7%FY 2022: -42.9%FY 2023: -39.7%FY 2024: -16.6%FY 2025: -33.2%
FY 2016 5y median -34.7% FY 2025
ROA -30.5%
FY 2016: -18.2%FY 2017: -20.4%FY 2018: -28.1%FY 2019: -122.9%FY 2020: -39.1%FY 2021: -26.6%FY 2022: -31.2%FY 2023: -37.0%FY 2024: -15.5%FY 2025: -30.5%
FY 2016 5y median -30.5% FY 2025

Growth (YoY)

Revenue -43.0%
FY 2016: 0.0%FY 2017: -17.5%FY 2018: 7.6%FY 2019: 113.2%FY 2020: -14.2%FY 2021: 124.2%FY 2022: 651.4%FY 2023: 5.9%FY 2024: 341.8%FY 2025: -43.0%
FY 2016 FY 2025
Operating Income -219.4%
FY 2016: 0.0%FY 2017: 16.4%FY 2018: -248.5%FY 2019: -79.0%FY 2020: -11.6%FY 2021: -36.3%FY 2022: 5.3%FY 2023: 1.2%FY 2024: 57.6%FY 2025: -219.4%
FY 2016 FY 2025
EPS (diluted) -150.4%
FY 2016: 0.0%FY 2017: -9.6%FY 2018: -193.0%FY 2019: -659.9%FY 2020: 75.3%FY 2021: 2.2%FY 2022: -9.1%FY 2023: 2.1%FY 2024: 58.2%FY 2025: -150.4%
FY 2016 FY 2025
Free Cash Flow -785.9%
FY 2016: 0.0%FY 2017: -161.3%FY 2018: -123.4%FY 2019: -87.3%FY 2020: -59.9%FY 2021: -21.0%FY 2022: 17.6%FY 2023: 8.7%FY 2024: 82.7%FY 2025: -785.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.8×
FY 2016: 6.0×FY 2017: 5.2×FY 2018: 9.4×FY 2019: 4.5×FY 2020: 3.9×FY 2021: 5.2×FY 2022: 1.9×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 1.8×
FY 2016: 8.0×FY 2017: 5.2×FY 2018: 9.4×FY 2019: 4.5×FY 2020: 3.9×FY 2021: 5.2×FY 2022: 1.8×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Debt / Equity 1.5×
FY 2016: -0.1×FY 2017: -0.0×FY 2018: -0.0×FY 2019: 0.1×FY 2020: 0.6×FY 2021: 0.9×FY 2022: 4.4×FY 2023: 29.7×FY 2024: 6.3×FY 2025: 1.5×
FY 2016 5y median 4.4× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 2.5×FY 2017: 0.1×FY 2018: 2.8×FY 2019: 0.5×FY 2020: 0.8×FY 2021: 0.8×FY 2022: -0.4×FY 2023: -1.0×FY 2024: -1.8×FY 2025: 0.4×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -22.4×
FY 2016: -36.1×FY 2017: -1.7×FY 2018: -9.3×FY 2019: -143×FY 2020: -109×FY 2021: -55.8×FY 2022: -16.7×FY 2023: -9.1×FY 2024: -5.7×FY 2025: -22.4×
FY 2016 5y median -16.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31